Exposure Consulting's Leading Environmental Scientist Dr. Alex LeBeau Offers Exclusive Media Interviews on the Growing PFAS Crisis
GlobeNewswire
2025-03-10

ORLANDO, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- There is an escalating crisis surrounding per- and polyfluoroalkyl substances (PFAS), also known as "forever chemicals." This has sparked nationwide concern as new research continues to expose their potential environmental and health risks. Today Exposure Consulting, alongside president Dr. Alex LeBeau, one of the leading experts in PFAS health risk assessment, is now offering exclusive interviews to media organizations, product manufacturers, municipal water providers, concerned organizations, and law firms seeking authoritative insights on the dangers of PFAS and the urgent need for action.

Connect With Dr. Alex LeBeau

Connect With Dr. Alex LeBeau

PFAS, a class of manmade chemicals found in countless consumer products, have been linked to a range of serious health issues, including cancer, immune system suppression, and developmental disorders. With these toxic substances now detected in drinking water, soil, and even in humans, the long-term consequences pose a significant public health concern.

"As new studies continue to confirm the widespread presence of PFAS in water systems, consumer products, and environmental reservoirs, we are at a pivotal moment in determining how we mitigate exposure and protect human health," said Dr. LeBeau, President of Exposure Consulting.

"The urgency of this issue cannot be overstated, and public awareness is critical in pushing for science-based regulations and remediation efforts."

Dr. LeBeau has been a featured expert in both local and national media across the United States, bringing a wealth of experience in environmental risk assessment, industrial contamination, and toxicology. His expertise has been sought after by industry leaders and legal professionals looking to navigate the complex and evolving landscape of PFAS regulations.

Media organizations interested in arranging a private interview with Dr. LeBeau to discuss the latest developments on PFAS, their impact on public health, and potential solutions are encouraged to reach out.

Exposure Consulting - Trusted partners

Exposure Consulting - Trusted partners

About Dr. Alex LeBeau & Exposure Consulting:

Dr. Alex LeBeau is a leading environmental scientist specializing in toxicology, industrial hygiene, and PFAS contamination. As the president of Exposure Consulting, he works with organizations, product manufacturers, and legal teams to assess environmental hazards and develop solutions for mitigating chemical exposure risks. His research and insights have been featured in major media outlets, and he continues to advocate for science-backed policies to protect public health.

For media inquiries and to schedule an interview, please contact:

Exposure Consulting
https://exposureconsulting.com

John Brocas
pr@exposureconsulting.com

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ff496a1b-fa28-40ad-aeb1-2baff6d8b3d5

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/6cfcb8da-648e-4ddd-9a86-5f99080d9cf7

https://www.globenewswire.com/NewsRoom/AttachmentNg/b0b9e421-0fe3-4618-8a30-7f2d6ab8f33c


Press Releases via Globe Newswire
NowVertical Enters Next Phase of Growth as Integration Unlocks Shareholder Value and Announces Further Debt Settlement Agreement
Silynxcom Announces Two New Orders from Elite IDF Special Forces Unit for In-Ear Headset Systems
Inspired Expands Global Partnership with Rush Street Interactive via RushBet in Mexico, Colombia, Peru and BetRivers in the U.S. State of Delaware
United Corporations Limited Announces Renewal of Normal Course Issuer Bid
Advanced Technology International Achieves Perfect Score in JSVA
SEALSQ Expands Global Reach with New Distribution and Sales Agreements Across Europe, Asia, and the Middle East
1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
Serstech receives an order of 2.1 MSEK from its partner Kaiser
CloudBees Celebrates 15 Years of DevOps Industry Impact and Continued Innovation
Kavaliro Sells Salesforce Division to Accordion in Strategic Move to Focus on Core Services
more...
more...
more...
more...
more...
more...